The Relationship between Oral Anti Diabetic Drugs with HBA1c, Obesity and Complications in Type 2 Diabetic Patients

Objective: Evoluation of oral anti diabetic medication used by type 2 diabetes mellitus patients in relation to glycemic control, body mass index and complications. Methods: 270 volunteer patients, over 18 years of age, who applied to Family Medicine Clinics of Okmeydan？ Training and Research Hospital, diagnosed with type 2 diabetes who were taking oral anti diabetic drugs for the last 6 months alone or in combination were taken to study. Patients with impaired fasting glucose and/or impaired glucose tolerance, patients using insulin were not included in the study. In the comparison, t-test and chi-square analyzes were used. P <0.05 was considered significant. Results: 46.7% of the participants were male, 53.3% were female and the average age of the group was 53.9 (± 0.7). 82 of 270 patients (30.4%) were found to have regular blood sugar and 188 (69.6%) were not found to have regular. Microvascular complications were detected in one of three individuals in the regular blood glucose group; this rate was higher in the irregular group. More macrovascular complications were observed in the irregular blood glucose group. It was revealed that those who have regular blood sugar mainly used single and/or dual drugs, those who have irregular blood sugar use more than double drugs. Conclusion: Despite the large number of oral anti diabetic treatment options, a significant number of patients with tip 2 diabetes mellitus are under the risk of living with poor glycemic control, obesity, and complication